No safe amount of lead in drinking water for patients with kidney disease, finds study Hina Zahid23 July 2021 2:45 AM GMTThe findings suggest that for patients with poor kidney function, there is no safe amount of lead in drinking water. Even low levels of lead conta...
SGLT2 inhibitor dapagliflozin safe and effective in patients with advanced kidney disease: Study Hina Zahid21 July 2021 12:45 PM GMTThe effects of dapagliflozin in patients with stage 4 CKD are similar to effects in patients with mild to moderate CKD. USA: The benefits of SGLT2...
Intraglomerular dysfunction may predict kidney failure in type 2 diabetes patients: Study Medha20 July 2021 3:30 AM GMTUSA: Intraglomerular dysfunction can predict kidney failure in type 2 diabetes (T2D) patients, suggests a recent study in Diabetes, the journal of the ...
A nomogram useful for screening atherosclerosis in CKD patients without dialysis: Study Dr. Shravani Dali20 July 2021 3:15 AM GMTA nomogram is beneficial and might be instrumental for detecting subclinical atherosclerosis in patients with CKD without dialysis, suggests a study ...
Prostatic artery embolization may do away with catheterization need in AUR patients: Study Medha20 July 2021 3:15 AM GMTChina: Prostatic artery embolization (PAE) can be used for achieving freedom from catheterization in patients with acute urinary retention (AUR)...
Diabetes: Study suggests SGLT2 inhibitors role in primary prevention of diabetic kidney disease Medha19 July 2021 5:18 AM GMTDelhi: Dapagliflozin, an SGLT2 inhibitor, may be used for the primary prevention of diabetic kidney disease, suggests recent results from DECLARE-TIMI ...
PROPr score validated in patients of hemodialysis or kidney transplant in new Study Hina Zahid19 July 2021 3:00 AM GMTCanada: A new study published in CJASN has established the validity of the score in patients on hemodialysis or who had recently received kidney...
FDA panel votes against use of Roxadustat for anaemia in CKD patients Dr. Shravani Dali17 July 2021 1:25 PM GMTFibroGen, Inc., a leading biopharmaceutical company headquartered in San Francisco recently announced that the Cardiovascular and Renal Drugs...
Kayexalate and Patiromer effective in lowering serum potassium concentration: Study Dr. Nandita Mohan17 July 2021 3:30 AM GMTBoth Kayexalate and Patiromer were effective in lowering the serum potassium concentration, according to a new research published in the American...
Mineralocorticoid receptor antagonists improve clinical outcomes of kidney failure: Study Dr. Shravani Dali16 July 2021 3:30 AM GMTMineralocorticoid receptor antagonists may give better treatment outcomes of patients with kidney failure on dialysis without increasing the risk of ...
Elevated non-HDL-C linked to higher mortality in patients undergoing peritoneal dialysis: Study Medha15 July 2021 4:15 AM GMTChina: An increased level of non-HDL-C raises the risk of cardiovascular (CV) mortality and all-cause mortality in patients undergoing peritoneal...
Sotagliflozin use linked to reduced risk of heart attack, heart failure and stroke in diabetics: Study Medha15 July 2021 3:30 AM GMTSotagliflozin is not FDA approved and if it is brought to the market, it would signify a major advance in the care of patients with diabetes, especiall...
